Inventor
Charles G. Clark
Inventor
Cherry Hill, NJ, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
A63BApparatus for physical training, gymnastics, swimming, climbing, or fencing2%
B60JWindows, windscreens, non-fixed roofs, doors, or similar devices for vehicles2%
B60NSeats specially adapted for vehicles2%
B60QArrangement of signalling or lighting devices, the mounting or supporting thereof or circuits therefor, for vehicles in general2%
B60RVehicles, vehicle fittings, or vehicle parts, not otherwise provided for2%
D05BSewing2%
PatentTitleYear
10,926,717Vehicle with integrated portable wireless speaker system20219,428,504'7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor'20169,403,774'Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors'20169,315,519'Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors'20169,108,981'Cyclic P1 linkers as factor XIa inhibitors'20158,901,115'Cyclic P1 linkers as factor XIa inhibitors'20147,960,569'Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20117,674,828'Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions'20107,388,021'Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20087,381,732'Pyrazolobenzamides and derivatives as factor Xa inhibitors'20087,235,575'Guanidine mimics as factor Xa inhibitors'20076,958,356'Guanidine mimics factor Xa inhibitors'20056,906,070'Guanidine mimics as factor Xa inhibitors'20056,858,616'Nitrogen containing heterobicycles as factor Xa inhibitors'20056,839,992'Quilting frame apparatus'20056,673,810'Imidazo-heterobicycles as factor Xa inhibitors'20046,602,871'Thrombin or factor Xa inhibitors'20036,541,639'Efficient ligand-mediated Ullmann coupling of anilines and azoles'20036,500,855'Thrombin or factor Xa inhibitors'20026,413,980'Nitrogen containing heterobicycles as factor Xa inhibitors'20026,403,583'Thrombin or factor Xa inhibitors'20026,369,227'Thrombin or factor Xa inhibitors'20026,339,099'Guanidine mimics as factor Xa inhibitors'20024,540,171'Variable resistance exercise apparatus'1985Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1985–2014Patents assigned to CLARK CHARLES G (2)· patent assignee history
1985Based in Westland, MI, US· patent location history
2002–2005Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (9)· patent assignee history
2002–2016Based in Cherry Hill, NJ, US· patent location history
2005Based in Breckenridge, TX, US· patent location history
2007–2016Patents assigned to BRISTOL MYERS SQUIBB CO (10)· patent assignee history
2021Patents assigned to BERG MATTHEW A (1)· patent assignee history
2021Patents assigned to CLARK COBY S (1)· patent assignee history
2021Based in Troy, MI, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 10 | 2007–2016 |
| BRISTOL MYERS SQUIBB PHARMA CO | 9 | 2002–2005 |
| CLARK CHARLES Gself | 2 | 1985–2014 |
| BERG MATTHEW A | 1 | 2021 |
| CLARK COBY Sself | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cherry Hill, New Jersey, US | 21 | 2002–2016 |
| Troy, MI, US | 1 | 2021 |
| Breckenridge, Texas, US | 1 | 2005 |
| Westland, MI, US | 1 | 1985 |